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ABSTRACT 
We present a sample introduction interface that allows direct on-chip processing of crude stool sam-
ples for the detection of Helicobacter pylori (H. pylori).  Efficient cell lysis and DNA extraction were 
achieved using stored reagents, reconstituted upon sample addition.  Clinical stool samples were ana-
lysed using the device and successful amplification of a H. pylori specific target was achieved.  
KEYWORDS: Clinical Diagnostics, DNA, Magnetic Extraction, Sample Preparation 
 
INTRODUCTION 
It is estimated that approximately two-thirds of the population harbours H. pylori, a Gram-negative 
microorganism that colonises the gastric mucosa in the human stomach and has been shown to have a 
significant role in the pathogenesis of gastric cancer [1].  H. pylori is most commonly identified using 
commercially available immunoassays to detect the H. pylori antigen in stool samples.  Clinical stool 
samples are particularly challenging for diagnostic analysis as they exhibit high variability in terms of 
sample consistency, contain PCR inhibitors and have low target analyte concentrations.  Here, the 
principle of IFAST (Immiscible Filtration Assisted by Surface Tension) [2] was adapted in order to 
enable the direct processing of stool samples for the detection of H. pylori, eliminating the need to pre-
treat the sample and reducing procedural times compared to conventional DNA kits.  To achieve this, 
the device featured a number of novel features: (i) a large-volume sample chamber that enabled a 40-
fold reduction in working volume, (ii) pre-loaded solid, detergent-free cell lysis and DNA binding 
agents that were reconstituted by the sample itself, and (iii) a real-world interface created using a 
septum-based sample introduction design. 
 
EXPERIMENTAL 
The microfluidic devices were produced from PDMS and included a septum-based sample 
introduction design (Fig. 1).  Solid chaotropic salt (guanidine hydrochloride, GuHCl) and dry 
superparamagnetic particles (PMPs) were stored in the sample chamber on-chip and reconstituted upon 
addition of stool sample. Following cell lysis and DNA binding, the PMPs were pulled via a magnet 
through a washing chamber containing an immiscible oil solution and into an elution chamber where 
the DNA was released into aqueous media for subsequent analysis.  Eluted DNA was examined for 
purity and concentration using a spectrophotometer, and amplified using the polymerase chain reaction 













Figure 1:  Schematic showing the design of the PDMS device and overview of the DNA extraction process, 
(a) sample loading & cell lysis, (b) mixing of PMPs with sample for DNA binding, (c) transfer of PMPs through 
the immiscible phase for washing, and (d) elution of DNA from the PMPs.  Schematics not to scale.  B) Real-
world interface featuring a septum-based stool sample introduction port. 
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RESULTS AND DISCUSSION 
Using E.coli as a model Gram-negative pathogenic target system, the on-chip cell lysis method, 
using stored reagents, was shown to be as effective (p = 0.928, ANOVA) as conventional off-chip lysis 
(Fig. 2) and reliable DNA extraction efficiencies were achieved across a wide range of added DNA 
concentrations (Fig. 3).  Clinical stool samples were then analysed for DNA concentration and purity 
after processing on the IFAST device.  As expected, the DNA concentrations obtained varied from 
patient to patient due to varying levels of infection (5.1 – 190 ng µL-1, average 59.3 ng µL-1).  
Comparison of the purity of the samples to their original appearance (based on the Bristol Stool Chart) 
showed a strong correlation (R2 = 0.96 and P<0.001 Pearson’s R), with more liquid samples (e.g. Types 
6 and 7) producing higher extracted DNA purities (1.0 – 2.0 purity, average 1.5).  Successful 
amplification of a H. pylori specific target (UreC gene – PCR product size 274 bp) was achieved on 
those stool samples extracted using the IFAST device.   
 
 
Figure 2:  Lysis efficiency of the stored 5 M GuHCl 
reagent both on- and off-chip (n=6) for 2.54 x 106 
(red) and 2.54 x 104 cells (blue). 
 
Figure 3:  DNA extraction efficiency from E. coli 
cells, showing a strong linear correlation between 
the amount of DNA added to the system (ng) and the 
amount of DNA recovered from the system (ng). 
 
CONCLUSION 
 This microfluidic approach offers advantages over commercial systems, such as Qiagen’s QIAamp 
Stool DNA Mini Kits, in the time taken for analysis (a 7-fold reduction), further pre-concentration of 
target DNA by eluting in a volume of 10 µL compared to 200 µL and ease-of-use (e.g. multiple 
centrifugation steps are not required).  The combination of a real-world interface for crude biological 
samples and rapid DNA extraction offers potential for the methodology to be used in point-of-care 
devices where rapid and efficient diagnosis of H. pylori could be important in eradicating the infection 
and reducing the risk of gastric cancer development.  
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